Imidazo[1,2-α]pyridines.: Part 2:: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors

被引：113

作者：

Byth, KF ^{[1
]}

Culshaw, JD ^{[1
]}

Green, S ^{[1
]}

Oakes, SE ^{[1
]}

Thomas, AP ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 09期

关键词：

CDK2; inhibitor;

D O I：

10.1016/j.bmcl.2004.02.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Exploration of SAR and optimisation of the imidazo[1,2-a]pyridine CDK inhibitors has lead to the discovery of novel, potent and selective inhibitors of the cyclin-dependent kinase CDK2. Understanding of SAR has identified positions Of Substitution, which allow modification of physical properties and offer the potential for in vivo optimisation. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：2245 / 2248

页数：4

共 26 条

[1] IMIDAZOLE DERIVATIVES .4. SYNTHESIS AND PHARMACOLOGIC ACTIVITY OF OXYGENATED DERIVATIVES OF IMIDAZO[1,2-ALPHA]PYRIDINE [J].

ALMIRANTE, L ;

MUGNAINI, A ;

DETOMA, N ;

GAMBA, A ;

MURMANN, W ;

HIDALGO, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (06) :1048-+

[2] Imidazo[1,2-a]pyridines:: A potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation [J].

Anderson, M ;

Beattie, JF ;

Breault, GA ;

Breed, J ;

Byth, KF ;

Culshaw, JD ;

Ellston, RPA ;

Green, S ;

Minshull, CA ;

Norman, RA ;

Pauptit, RA ;

Stanway, J ;

Thomas, AP ;

Jewsbury, PJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) :3021-3026

[3] Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases [J].

Barvian, M ;

Boschelli, DH ;

Cossrow, J ;

Dobrusin, E ;

Fattaey, A ;

Fritsch, A ;

Fry, D ;

Harvey, P ;

Keller, P ;

Garrett, M ;

La, F ;

Leopold, W ;

McNamara, D ;

Quin, M ;

Trumpp-Kallmeyer, S ;

Toogood, P ;

Wu, ZP ;

Zhang, EL .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (24) :4606-4616

[4] S-TRIAZOLOPYRIMIDINES .4. SYNTHESIS AS POTENTIAL THERAPEUTIC AGENTS [J].

BEE, JA ;

ROSE, FL .

JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1966, (22) :2031-&

[5] AN IMPROVED GENERAL-SYNTHESIS OF 4-ARYL-5-PYRIMIDINECARBOXYLATES [J].

BREAUX, EJ ;

ZWIKELMAIER, KE .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 1981, 18 (01) :183-184

[6] Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists [J].

Chen, YNP ;

Sharma, SK ;

Ramsey, TM ;

Jiang, L ;

Martin, MS ;

Baker, K ;

Adams, PD ;

Bair, KW ;

Kaelin, WG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4325-4329

[7] SELECTIVE THROMBOXANE SYNTHETASE INHIBITORS .1. 1-[(ARYLOXY)ALKYL]-1H-IMIDAZOLES [J].

CROSS, PE ;

DICKINSON, RP ;

PARRY, MJ ;

RANDALL, MJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1427-1432

[8] Novel, potent and selective cyclin D1/CDK4 inhibitors:: Indolo[6,7-a]pyrrolo[3,4-c]carbazoles [J].

Engler, TA ;

Furness, K ;

Malhotra, S ;

Sanchez-Martinez, C ;

Shih, C ;

Xie, W ;

Zhu, GX ;

Zhou, X ;

Conner, S ;

Faul, MM ;

Sullivan, KA ;

Kolis, SP ;

Brooks, HB ;

Patel, B ;

Schultz, RM ;

DeHahn, TB ;

Kirmani, K ;

Spencer, CD ;

Watkins, SA ;

Considine, EL ;

Dempsey, JA ;

Ogg, CA ;

Stamm, NB ;

Anderson, BD ;

Campbell, RM ;

Vasudevan, V ;

Lytle, ML .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (14) :2261-2267

[9]

Furet P, 2002, BIOORG MED CHEM LETT, V12, P221, DOI 10.1016/S0960-894X(01)00715-6

[10]

FURTE P, 2001, J COMPUT AID MOL DES, V15, P489

← 1 2 3 →